Navigation Links
Quantros Announces Partnership With Hospital Accreditation Agency DNV
Date:11/13/2009

SAN FRANCISCO, Nov. 13 /PRNewswire/ -- Quantros, a leading software and services provider for the healthcare industry, announces that it has partnered with Det Norske Veritas Healthcare, Inc. (DNV). DNV was recognized in 2008 by the Centers for Medicare and Medicaid Services (CMS) as an authorized accreditation organization. Quantros will now integrate that company's accreditation standards into the Quantros ACE(TM) software application.

DNV's Executive Vice President, Patrick Horine, explains their role, "Many hospitals across the country are choosing DNV to get more from their accreditation efforts. Our NIAHOSM standards are tightly coupled to the Medicare Conditions of Participation and introduce ISO 9001 quality methods into the hospital setting. We use accreditation surveys as the vehicle to create self-sustaining improvement - continual quality."

The DNV standards will be available in the on-line library of ACE, Quantros' accreditation compliance and quality management product. Quantros ACE is a web-based system designed to collect, monitor, report and analyze accreditation and compliance data across all levels of an organization. ACE monitors compliance with multiple accreditation and regulatory standards including those of The Joint Commission, Center for Medicare and Medicaid Services (CMS), ISO and now DNV.

DNV is the first new organization to be granted "deeming authority" for Medicare participation in over 30 years. The organization is only one of three recognized accrediting bodies. The Joint Commission and the American Osteopathic Association are the others.

DNV's Executive Vice President, Patrick Horine attests to the strategic importance of a partnership with Quantros for hospitals seeking accreditation, "Automating standards compliance with Quantros ACE will provide hospitals access to state of the art capabilities to streamline their workflow. We are pleased to partner with Quantros."


'/>"/>

SOURCE Quantros
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a preliminary prospectus supplement to its effective shelf registration statement ... with securities regulatory authorities in each of the provinces of ... offering of its common shares to raise gross proceeds of ... also grant to the underwriters of the Offering an option, ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... Two months ago, Suyima Torres, 28, died from ... session of a silicone treatment for gluteus augmentation at Cuerpos ... performed by a mystery Venezuelan doctor in a center that ... Bernabe Vazquez of Bayshore Cosmetic Surgery , women suffering ... are not board certified is more common than people think. ...
(Date:6/18/2013)... Calif. (PRWEB) June 18, 2013 David ... professor of Family Medicine for the College of Osteopathic ... Health Sciences has been elected president of the ... Edmund G. Brown Jr. appointed Connett, a 1984 alumnus ... OMBC members recently elected Connett to the position during ...
(Date:6/18/2013)... People with HIV are more likely to keep their ... if they feel their physician listens, explains things ... a "case," new Johns Hopkins research suggests. , "If ... to them, they feel that doctor has their best ... follow medical advice," says study leader Tabor E. Flickinger, ...
(Date:6/18/2013)... of investigators co-led by Weill Cornell Medical College is ... research, similar to the kind of risk and benefit ... no dynamic research framework to systematically detect devices and ... may even be harmful," says co-lead investigator Dr. Art ... the June 18 issue of the British Medical ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Respect may be the key to stopping patient 'no shows' 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
... ... SRI International, an independent nonprofit research and development institute, announced ... its Center for Health Sciences. This new SRI group of neuroscientists and ... of funding from the National Institutes of Health (NIH), including the ...
... , LAVAL, QC and ... Inc. (TSX: DDS; NASDAQ: DDSS ) today announced the closing ... units were sold at a price of US$1.70 per ... were US$18,150,000 after deducting underwriting discounts and commissions, and ...
... how human genes interact with their environment to boost ... edition of the American Journal of Human Genetics ... for specific gene variants linked to human diseases can ... genes and environmental factors influence common human diseases like ...
... the battlefield, a new UCLA study of U.S. Civil War ... units characterized by a strong esprit de corps were much ... heart condition than veterans from less cohesive companies, two UCLA ... expect your buddy to have your back," said Dora Kosta, ...
... ... of IT Infrastructure , ... Reston, VA (PRWEB) February 18, 2010 -- Carahsoft Technology Corp. , the trusted ... provider of extreme-scale grid computing software and services. Carahsoft is placing Parabon ...
... ... team, names Estelle Cummings as Area Vice-President of Sales , ... Cambridge, MD (PRWEB) February 18, 2010 -- ... V.P. of Sales for the CCBsure®, technology program . Cummings oversees new ...
Cached Medicine News:Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 2Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 3Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 4Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 5Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 6Health News:Labopharm announces closing of US$20 million public offering of units 2Health News:Labopharm announces closing of US$20 million public offering of units 3Health News:UCLA study reveals how genes interact with their environment to cause disease 2Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 2Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 3Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 4Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 3Health News:CCBsure Names New Area Vice-President of Sales 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: